EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The antiangiogenic peptide VIAN-c4551 inhibits lung melanoma metastasis in mice by reducing pulmonary vascular permeability

Alma Lorena Perez, Magdalena Zamora, Manuel Bahena, Regina Aramburo-Williams, Elva Adan-Castro, Daniela Granados-Carrasco, Thomas Bertsch, Jakob Triebel iD, Gonzalo Martinez de la Escalera, Juan Pablo Robles, Carmen Clapp

PLOS One · 2025

DOI: 10.1371/journal.pone.0316983 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Alma Lorena Perez und 10 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM), Querétaro, México. Hauptthemen laut MEDLINE: Lung Neoplasms, Capillary Permeability, Melanoma, Experimental, Angiogenesis Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México, Consejo Nacional de Ciencia y Tecnología.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cancer cells drive the increase in vascular permeability mediating tumor cell extravasation and metastatic seeding. VIAN-c4551, an antiangiogenic peptide analog of vasoinhibin, inhibits the growth and vascularization of melanoma tumors in mice. Because VIAN-c4551 is a potent inhibitor of vascular permeability, we evaluated whether its antitumor action extended to a reduction in metastasis generation.

Methods

Circulating levels of vascular endothelial growth factor (VEGF), lung vascular permeability, melanoma cell extravasation, and melanoma pulmonary nodules were assessed in C57BL/6J mice intravenously inoculated with murine melanoma B16-F10 cells after acute treatment with VIAN-c4551. VEGF levels, transendothelial electrical resistance, and transendothelial migration in cocultures of B16-F10 cells and endothelial cell monolayers supported the findings.

Results

B16-F10 cells increased circulating VEGF levels and elevated lung vascular permeability 2 hours after inoculation. VIAN-c4551 prevented enhanced vascular permeability and reduced melanoma cell extravasation after 2 hours and the number and size of macroscopic and microscopic melanoma tumors in lungs after 17 days. In vitro, VIAN-c4551 suppressed the B16-F10 cell-induced and VEGF mediated increase in endothelial cell monolayer permeability and the transendothelial migration of B16-F10 cells. No detrimental effect of VIAN-c4551 was observed on hematological, biochemical, and histological parameters after its intravenous administration in mice for 14 days.

Conclusions

These findings support the inhibition of distant vascular permeability for the prevention of tumor metastasis and unveil the anti-vascular permeability factor VIAN-c4551 as a potential and safe therapeutic drug able to prevent metastasis generation by lowering the extravasation of melanoma cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsCapillary PermeabilityMelanoma, ExperimentalAngiogenesis InhibitorsAnimalsMiceVascular Endothelial Growth Factor AMice, Inbred C57BLCell Line, TumorLungHumansTransendothelial and Transepithelial Migration

Substanzen

Vascular Endothelial Growth Factor AAngiogenesis Inhibitors

Autor:innen und Institutionen

  • Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM), Querétaro, México.
  • Institute for Clinical Chemistry, Laboratory Medicine and Transfusion Medicine, Nuremberg General Hospital & Paracelsus Medical University, Nuremberg, Germany.
  • VIAN Therapeutics, San Francisco, California, United States of America.

ORCID-Profile: Jakob Triebel

Förderung

  • Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México
  • Consejo Nacional de Ciencia y Tecnología

Zitieren

APA

Perez, A. L., Zamora, M., Bahena, M., Aramburo-Williams, R., Adan-Castro, E., Granados-Carrasco, D., Bertsch, T., Triebel, J., Martinez de la Escalera, G., Robles, J. P., & Clapp, C. (2025). The antiangiogenic peptide VIAN-c4551 inhibits lung melanoma metastasis in mice by reducing pulmonary vascular permeability. PLOS One. https://doi.org/10.1371/journal.pone.0316983

Vancouver

Perez AL, Zamora M, Bahena M, Aramburo-Williams R, Adan-Castro E, Granados-Carrasco D, et al. The antiangiogenic peptide VIAN-c4551 inhibits lung melanoma metastasis in mice by reducing pulmonary vascular permeability. PLOS One. 2025. doi:10.1371/journal.pone.0316983

BibTeX
@article{Perez2025,
  author = {Perez, Alma Lorena and Zamora, Magdalena and Bahena, Manuel and Aramburo-Williams, Regina and Adan-Castro, Elva and Granados-Carrasco, Daniela and Bertsch, Thomas and Triebel, Jakob and Martinez de la Escalera, Gonzalo and Robles, Juan Pablo and Clapp, Carmen},
  title = {The antiangiogenic peptide VIAN-c4551 inhibits lung melanoma metastasis in mice by reducing pulmonary vascular permeability},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0316983}
}
Kostenlos starten →